» Articles » PMID: 20698555

Cellular Uptake, Cytotoxicity, and Innate Immune Response of Silica-titania Hollow Nanoparticles Based on Size and Surface Functionality

Overview
Journal ACS Nano
Specialty Biotechnology
Date 2010 Aug 12
PMID 20698555
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Silica-titania hollow nanoparticles (HNPs) with uniform diameters of 25, 50, 75, 100, and 125 nm were fabricated by dissolution and redeposition method in order to evaluate size dependent cellular response. Surface-modified HNPs with cationic, anionic, and neutral functional group were prepared by silane treatment. We systematically investigated cellular internalization, toxicity, and innate immune response of HNPs in human breast cancer (SK-BR-3) and mouse alveolar macrophage (J774A.1) cells. Size- and surface functionality-dependent cellular uptake of HNPs was investigated by fluorescence labeling (fluorescein isothiocyanate), inductively coupled plasma-emission spectroscopy, and ultrastructural resolution using transmission electron microscopy. Viability, reactive oxygen species, and apoptosis/necrosis of HNP-treated J774A.1 revealed the size-dependent phenomenon. Innate immune response of HNP-treated macrophages was measured by three cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor α. Among the HNPs of different sizes, 50-nm HNPs demonstrated the highest toxic influence on macrophages. Among the HNPs with surface functionalities, cationic HNPs demonstrated the most toxic effect on J774A.1 and the highest uptake efficiency. The toxicity results of HNP-treated macrophages were consistent with the cellular internalization efficiency. These findings provide size- and surface functionality-dependent nanotoxicity and uptake of HNPs, and lead to HNPs for bioapplications such as drug delivery and imaging probe.

Citing Articles

Inhibition of IRF3-STING axis interaction in silicosis using natural compounds: an in-silico study using molecular docking, ADMET, molecular dynamics and MMPBSA approach.

Sood A, Kulharia M In Silico Pharmacol. 2024; 13(1):1.

PMID: 39659978 PMC: 11625707. DOI: 10.1007/s40203-024-00290-5.


Enterosorbents in complex therapy of food allergies: a focus on digestive disorders and systemic toxicity in children.

Shichkin V, Kurchenko O, Okhotnikova E, Chopyak V, Delfino D Front Immunol. 2023; 14:1210481.

PMID: 37901242 PMC: 10611465. DOI: 10.3389/fimmu.2023.1210481.


Shape Anisotropy-Governed High-Performance Nanomagnetosol for In Vivo Magnetic Particle Imaging of Lungs.

Nigam S, Mohapatra J, Makela A, Hayat H, Rodriguez J, Sun A Small. 2023; 20(5):e2305300.

PMID: 37735143 PMC: 10842459. DOI: 10.1002/smll.202305300.


Vasculature organotropism in drug delivery.

Amruta A, Iannotta D, Cheetham S, Lammers T, Wolfram J Adv Drug Deliv Rev. 2023; 201:115054.

PMID: 37591370 PMC: 10693934. DOI: 10.1016/j.addr.2023.115054.


Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy.

Wahab S, Ghazwani M, Hani U, Hakami A, Almehizia A, Ahmad W Molecules. 2023; 28(3).

PMID: 36770883 PMC: 9920693. DOI: 10.3390/molecules28031216.